propranolol has been researched along with Vascular Malformations in 11 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Vascular Malformations: A spectrum of congenital, inherited, or acquired abnormalities in BLOOD VESSELS that can adversely affect the normal blood flow in ARTERIES or VEINS. Most are congenital defects such as abnormal communications between blood vessels (fistula), shunting of arterial blood directly into veins bypassing the CAPILLARIES (arteriovenous malformations), formation of large dilated blood blood-filled vessels (cavernous angioma), and swollen capillaries (capillary telangiectases). In rare cases, vascular malformations can result from trauma or diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol is a nonselective β-adrenergic receptor (AR) blocker that has been the first-line therapy for problematic infantile hemangioma (IH), the most frequent childhood vascular tumor." | 8.12 | A transcription factor is the target of propranolol treatment in infantile hemangioma. ( Boscolo, E; Schrenk, S, 2022) |
| "Haemangiomas are the most common soft tissue tumours in infancy, occurring in approximately 5-10% of 1-year-old children." | 5.36 | Propranolol as a novel treatment for congenital visceral haemangioma. ( Cornette, L; Decaluwe, W; Van Geet, C; Vandelanotte, M; Vanlander, A, 2010) |
| "Propranolol is a nonselective β-adrenergic receptor (AR) blocker that has been the first-line therapy for problematic infantile hemangioma (IH), the most frequent childhood vascular tumor." | 4.12 | A transcription factor is the target of propranolol treatment in infantile hemangioma. ( Boscolo, E; Schrenk, S, 2022) |
| " The most common vascular tumor is infantile hemangioma, which treatment, when necessary, is propranolol." | 3.88 | [Benign aggressive vascular anomalies in children]. ( Boccara, O; Léauté-Labrèze, C; Maruani, A, 2018) |
| "Oral propranolol has become first-line intervention for problematic infantile hemangioma (IH) that is not amenable to topical or intralesional therapies." | 1.46 | Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma. ( Alomari, MH; Goss, JA; Greene, AK; Konczyk, DJ; Maclellan, RA, 2017) |
| "This case report describes propranolol treatment of vascular malformations such as Klippel-Trénaunay syndrome or Parkes-Weber syndrome in adults." | 1.42 | Successful treatment of a congenital extra-truncal vascular malformation by orally administered propranolol. ( Buecker, A; Janssen, E; Müller, CS; Pföhler, C; Vogt, T, 2015) |
| "Haemangiomas are the most common soft tissue tumours in infancy, occurring in approximately 5-10% of 1-year-old children." | 1.36 | Propranolol as a novel treatment for congenital visceral haemangioma. ( Cornette, L; Decaluwe, W; Van Geet, C; Vandelanotte, M; Vanlander, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Schrenk, S | 1 |
| Boscolo, E | 1 |
| Li, L | 1 |
| Yang, B | 1 |
| Wei, L | 1 |
| Zhang, B | 1 |
| Han, XF | 1 |
| Xu, ZG | 1 |
| Ma, L | 1 |
| Díaz-Fontenla, F | 1 |
| Castillo-Pradillo, M | 1 |
| Díaz-Gómez, A | 1 |
| Ibañez-Samaniego, L | 1 |
| Gancedo, P | 1 |
| Guzmán-de-Villoria, JA | 1 |
| Fernández-García, P | 1 |
| Bañares-Cañizares, R | 1 |
| García-Martínez, R | 1 |
| Goss, JA | 1 |
| Konczyk, DJ | 1 |
| Alomari, MH | 1 |
| Maclellan, RA | 1 |
| Greene, AK | 1 |
| Boccara, O | 1 |
| Maruani, A | 1 |
| Léauté-Labrèze, C | 1 |
| Pföhler, C | 1 |
| Janssen, E | 1 |
| Buecker, A | 1 |
| Vogt, T | 1 |
| Müller, CS | 1 |
| Trenor, CC | 1 |
| Slaughter, KA | 1 |
| Chen, T | 1 |
| Williams, E | 1 |
| Vanlander, A | 1 |
| Decaluwe, W | 1 |
| Vandelanotte, M | 1 |
| Van Geet, C | 1 |
| Cornette, L | 1 |
| Freshwater, MF | 1 |
| Blei, F | 1 |
3 reviews available for propranolol and Vascular Malformations
| Article | Year |
|---|---|
Medical management of vascular anomalies.
Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Bevacizumab; Clinical Decision-Making; Drug Th | 2016 |
Vascular Lesions.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Hemangioma; Humans; Plastic Surgery Procedur | 2016 |
Medical management of vascular anomalies.
Topics: Adrenergic beta-Antagonists; Hemangioendothelioma; Hemangioma; Humans; Kasabach-Merritt Syndrome; Pr | 2012 |
8 other studies available for propranolol and Vascular Malformations
| Article | Year |
|---|---|
A transcription factor is the target of propranolol treatment in infantile hemangioma.
Topics: Adrenergic beta-Antagonists; Animals; Child; Hemangioma; Humans; Mice; Propranolol; SOXF Transcripti | 2022 |
Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies.
Topics: Adenosine Triphosphate; Hemangioma, Capillary; Humans; Infant; Propranolol; Vascular Malformations | 2020 |
Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism.
Topics: Adrenergic beta-Antagonists; Alcoholism; Ammonia; Antithyroid Agents; Brain; Carbimazole; Diagnosis, | 2017 |
Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma.
Topics: Adrenergic beta-Antagonists; Adult; Child; Child, Preschool; Diagnostic Errors; Female; Hemangioma, | 2017 |
[Benign aggressive vascular anomalies in children].
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Arteriovenous Malformations; Child; Child, Pres | 2018 |
Successful treatment of a congenital extra-truncal vascular malformation by orally administered propranolol.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Female; Humans; Klippel-Trenaunay-Weber Sy | 2015 |
Propranolol as a novel treatment for congenital visceral haemangioma.
Topics: Abdominal Neoplasms; Hemangioma; Humans; Infant, Newborn; Male; Propranolol; Umbilical Cord; Vascula | 2010 |
Treatment of vascular anomalies of the upper extremity.
Topics: Child; Child, Preschool; Female; Hemangioma; Humans; Male; Propranolol; Radiography; Risk Assessment | 2011 |